Borrelia Burgdorferi Infection clinical trials
12 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
- Human Immune Response to Ixodes Scapularis Tick Bites
- Evaluation, Treatment, and Follow-up of Patients With Lyme Disease
- Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
- A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
- Navigating Pregnancy and Parenthood With Lyme Disease
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Rheumatology Patient Registry and Biorepository
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
- Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy
- Quest to Analyze One Thousand Humans Meditating
- A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Borrelia Burgdorferi Infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.